FIS

Fidelity National Information Services

$38.99

-2.89%
Nov 3, 2026
Bobby Quantitative Model
Fidelity National Information Services (FIS) is a global financial technology provider that delivers core banking processing, payment infrastructure, capital markets and wealth-management software, and issuer-processing services to banks, brokers, and asset managers across more than 100 countries. Following the divestiture of its Worldpay merchant-acquiring stake and the concurrent acquisition of Global Payments' issuer-processing business, FIS has repositioned itself as a pure-play banking and capital-markets technology vendor rather than a merchant-acquirer hybrid, competing with the likes of Fiserv, Jack Henry, and Broadridge. The investor narrative is now dominated by the post-Worldpay portfolio reset: shareholders are debating whether the issuer-processing acquisition can restore mid-single-digit organic growth and whether management can convert the elevated leverage taken on to fund the deal into deleveraging and buybacks. That debate has been sharpened by a brutal share-price decline over the past year, a one-off tax-affected earnings distortion in Q1 2026, and a recent stabilization in the stock that has bulls pointing to a deep value setup and bears citing structural growth and balance-sheet concerns.

People also watch

IBM

IBM

IBM

Analysis
Accenture

Accenture

ACN

Analysis
Cognizant Technology Solutions

Cognizant Technology Solutions

CTSH

Analysis
Fiserv

Fiserv

FISV

Analysis
Broadridge Financial Solutions

Broadridge Financial Solutions

BR

Analysis

BobbyInvestment Opinion: Should I buy FIS Today?

Rating: Hold with a constructive, value-oriented bias. The core thesis is that FIS trades at 5.80x consensus forward EPS of $7.90 — an extreme discount that already prices in substantial execution failure — while the 25-analyst consensus of 'buy' (mean rating 2.23) and $47.04 average target imply roughly +22% upside from $38.55; the problem is that the evidence for a durable re-rating is not yet in hand, with Wells Fargo and UBS downgrading in August and Deutsche Bank/Baird holding Neutral in late September.

Supporting evidence cuts both ways but tilts modestly positive on valuation. The forward PE of 5.80x sits far below the mid-teens-to-low-twenties multiples typical of scaled technology-services processors, and the $2.705 billion TTM free cash flow against a roughly $19.9 billion market cap implies a ~13.6% FCF yield that comfortably funds the 2.47% dividend. Revenue of $3.377 billion in Q2 2026 grew 29.09% year-over-year, and operating margin of 15.01% ($507 million) is respectable before the $200 million quarterly interest drag. The catch is that the 29% growth is largely acquisition arithmetic, gross margin has compressed to 34.76% from 42.45% in Q3 2025, and the 3.58% net margin plus 0.589 current ratio show the balance sheet is doing real damage to reported profitability — which is why EV/EBITDA of 16.24x and P/S of 3.22x are not statistically cheap on an enterprise basis.

Three risks could invalidate the thesis: (1) organic growth decelerating toward low single digits as the issuer-processing acquisition laps, which would make the 5.80x forward PE a value trap rather than a bargain; (2) deleveraging stalling at 0.96 debt-to-equity with $200 million of quarterly interest expense, forcing a choice between debt paydown, buybacks, and the dividend; and (3) further analyst downgrades if a weak quarter breaks the $32.10 52-week low. This Hold would upgrade to Buy if organic revenue growth is confirmed in the mid-single digits and debt-to-equity falls below 0.8, or downgrade to Sell if gross margin drops below 33% or the stock breaks decisively under $32.10. Verdict: undervalued relative to its own multi-year band (P/S of 3.22x versus 16.34x in Q2 2025) but only fairly valued on an enterprise basis — a deep-value setup that requires execution proof before it deserves a full Buy.

Sign up to view all

FIS 12-Month Price Forecast

FIS presents a classic deep-value-versus-value-trap setup: the 5.80x forward PE and ~13.6% FCF yield are compelling, but they sit alongside a 3.58% net margin, 0.589 current ratio, and $200 million of quarterly interest expense that justify a meaningful discount to higher-quality processors. The 29% revenue growth is real but heavily inorganic, and gross margin compression from 42.45% in Q3 2025 to 34.76% in Q2 2026 shows the mix shift is already eroding profitability. Analyst sentiment captures the standoff precisely — a 'buy' consensus with a $47.04 average target but a $37-$77 range and August downgrades from Wells Fargo and UBS — meaning the community likes the valuation but is waiting for proof of execution. I would upgrade to bullish if organic growth is confirmed in the mid-single digits and debt-to-equity falls below 0.8, and downgrade to bearish if gross margin drops below 33% or the stock breaks the $32.10 52-week low. With a beta of 0.828 and a 17.17% one-month rally off the low, the near-term setup favors patience over aggressive accumulation.

Historical Price
Current Price $38.99
Average Target $46.00
High Target $77.00
Low Target $30.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Fidelity National Information Services's 12-month outlook, with a consensus price target around $47.04 and implied upside of +20.6% versus the current price.

Average Target

$47.04

30 analysts

Implied Upside

+20.6%

vs. current price

Analyst Count

30

covering this stock

Price Range

$37 - $77

Analyst target range

Buy
14 (47%)
Hold
15 (50%)
Sell
1 (3%)

Coverage is robust, with 25 analysts and a consensus recommendation of "buy" (mean rating 2.23 on a scale where lower is more bullish). The average target price of $47.04 implies roughly +22% upside from the $38.55 current price, and consensus forward EPS of $7.90 and revenue of $15.15 billion underpin that view. Sentiment is constructive but not euphoric — the mean rating sits in the low-Buy zone, and the recent institutional tape shows a clear tilt toward caution: Wells Fargo downgraded to Equal Weight from Overweight on August 25, UBS cut to Neutral from Buy on August 5, and Deutsche Bank and Baird reiterated Hold/Neutral in late September, while TD Cowen, RBC, and Cantor maintained Buy/Outperform/Overweight. The net picture is a consensus that likes the valuation but is waiting for proof of execution.

The target range of $37.00 to $77.00 is exceptionally wide — the high is more than double the low — which signals high uncertainty and low conviction rather than a tightly clustered view. The $77 high target implies roughly 100% upside and would require multiple expansion toward historical norms plus successful integration of the issuer-processing acquisition and visible organic growth acceleration; the $37 low target sits essentially at the current price and prices in continued margin compression, elevated interest costs, and skepticism that the portfolio reset creates value. Notably, the low target is below the $47.04 average and only marginally above the $32.10 52-week low, meaning the bear case is already largely reflected in spot. With a spread this wide and recent downgrades outnumbering upgrades, the analyst community is effectively saying the risk/reward is attractive but the outcome distribution is bimodal — position sizing should reflect that binary execution risk.

Drowning in data?

Find the real signal!

Bulls vs Bears: FIS Investment Factors

The bear case currently has stronger evidence on the tape and the balance sheet: a 38% one-year decline, a 0.589 current ratio, $200 million quarterly interest expense, and a 3.58% net margin all argue that the market is pricing genuine fundamental deterioration, not just sentiment. The bull case rests on a 5.80x forward PE, a 13.6% FCF yield, and a 22% analyst-target upside that assumes earnings normalize and leverage comes down. The single most important tension is whether the 29% revenue growth is durable organic expansion or merely acquisition arithmetic — if organic growth proves mid-single-digit and deleveraging stalls, the low multiple is a value trap; if integration succeeds and FCF converts to debt paydown, the re-rating could be violent given the 2.96 short ratio and 77% gap to the 52-week high. Recent downgrades (Wells Fargo, UBS) versus maintained Buys (TD Cowen, RBC, Cantor) capture exactly this 'likes the valuation, waiting for proof of execution' standoff.

Bullish

  • Deep-value 5.8x forward PE: At $38.55, FIS trades at just 5.80x consensus forward EPS of $7.90, an optically extreme discount to the mid-teens-to-low-twenties multiples typical of technology-services processors. Even after acknowledging the 3.58% net margin and 0.96 debt-to-equity that justify some discount, the gap implies the market is pricing near-permanent earnings impairment rather than a normalized recovery.
  • Revenue re-accelerating 29% YoY: Q2 2026 revenue of $3.377 billion grew 29.09% versus $2.616 billion in Q2 2025, and the sequential climb from $2.812 billion in Q4 2025 to $3.295 billion in Q1 2026 confirms a structural step-up rather than seasonality. Banking Solutions at $2.483 billion plus Capital Market Solutions at $810 million gives FIS a scaled, recurring core-banking franchise.
  • Analyst target implies 22% upside: The 25-analyst consensus is 'buy' (mean rating 2.23) with an average target of $47.04, roughly +22% from the $38.55 spot. The $37 low target sits essentially at the current price, meaning the bear case is already largely discounted in the quote.
  • Solid $2.7B free cash flow: TTM free cash flow of $2.705 billion against a $19.9 billion market cap implies a roughly 13.6% FCF yield, which is unusually high for a scaled fintech processor. Q2 2026 alone generated $238 million of FCF on $494 million operating cash flow after $256 million capex, funding both the 2.47% dividend and deleveraging.

Bearish

  • Brutal 38% one-year decline: FIS is down 38.21% over the trailing year and 41.25% YTD versus the S&P 500's +10.80% and +10.82%, producing relative strength of -49.01% and -52.07%. The -52.69% max drawdown and a price at only ~18.5% of the $32.10-$68.37 52-week range confirm a severe, unresolved de-rating.
  • Leverage and tight liquidity: Debt-to-equity of 0.959 (56.9% debt-to-capitalization) and a current ratio of just 0.589 signal a balance sheet stretched by the issuer-processing acquisition. Q1 2026 showed $7.953 billion of debt repayment alongside $7.859 billion of acquisitions, and $200 million of quarterly interest expense is crushing the 3.58% net margin.
  • Earnings quality is poor: Trailing PE of 89.8x versus forward PE of 5.80x is an enormous gap that reflects a Q1 2026 one-off $1.946 billion non-operating gain inflating EPS to $4.59 while trailing EPS sits at $0.011. A 221.7% GAAP payout ratio and negative PEG of -1.88 underscore how distorted reported profitability currently is.
  • Analyst downgrades outpacing upgrades: Wells Fargo cut to Equal Weight on August 25 and UBS to Neutral on August 5, while Deutsche Bank and Baird reiterated Hold/Neutral in late September. The $37-$77 target range (high more than double the low) signals low conviction and a bimodal outcome distribution rather than a clustered bullish view.

FIS Technical Analysis

FIS is in a pronounced primary downtrend that has only recently begun to base. The stock is down 38.21% over the trailing year and 41.25% year-to-date, a staggering underperformance versus the S&P 500's +10.80% 1-year and +10.82% YTD returns, producing relative strength readings of -49.01% (1Y) and -52.07% (YTD). At $38.55, the shares sit at roughly 18.5% of the 52-week range between the $32.10 low and $68.37 high — closer to the floor than the ceiling, which historically flags either a capitulation value zone or a falling knife, and the -52.69% max drawdown confirms how severe the de-rating has been. The 52-week high of $68.37 is now 77% above spot, underscoring how much ground would need to be reclaimed for the trend to flip.

Short-term momentum, however, has turned decisively positive and is diverging sharply from the longer-term trend. The stock has rallied 17.17% over the past month versus a -1.81% decline for SPY, a relative strength spread of +18.98 percentage points, and it gained 3.41% on the latest session alone (previous close $37.28 to $38.55) on volume of 13.7 million shares. That one-month surge stands in stark contrast to the -13.89% three-month and -17.17% six-month changes, meaning the rebound is very recent and has not yet repaired the intermediate trend. This kind of sharp counter-trend bounce off a deep low often signals short-covering or mean reversion rather than a confirmed reversal, and with a short ratio of 2.96 there is a meaningful borrow to squeeze; traders should watch whether the move holds above the $36-37 area on declining volume before treating it as a genuine trend change.

Key technical levels are well defined. Support rests at the $32.10 52-week low, with a secondary shelf around $32.44-$33.10 where the October basing occurred; a breakdown below $32.10 would signal a fresh leg lower and likely trigger momentum-driven selling. Resistance sits at the $68.37 52-week high, but the more actionable near-term hurdle is the $42-$47 zone where the stock repeatedly failed in July and August — a breakout above $47 would be the first evidence of a durable trend reversal. Volatility is a mitigating factor: beta of 0.828 means FIS is roughly 17% less volatile than the market, so position sizing can be somewhat larger than for a high-beta name, though the -52.69% drawdown proves that low beta has not protected holders from severe idiosyncratic risk.

fundamental_analysis

Beta

0.85

0.85x market volatility

Max Drawdown

-52.7%

Largest decline past year

52-Week Range

$32-$68

Price range past year

Annual Return

-37.3%

Cumulative gain past year

PeriodFIS ReturnS&P 500
1m+20.2%-2.0%
3m-9.0%-2.0%
6m-17.5%+3.1%
1y-37.3%+10.4%
ytd-40.6%+10.6%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

FIS Fundamental Analysis

Revenue is re-accelerating sharply, though the optics are heavily distorted by the issuer-processing acquisition. Q2 2026 revenue of $3.377 billion grew 29.09% year-over-year versus $2.616 billion in Q2 2025, and the sequential progression from $3.295 billion in Q1 2026 and $2.812 billion in Q4 2025 confirms the step-up is structural rather than seasonal. Segment disclosure shows Banking Solutions at $2.483 billion and Capital Market Solutions at $810 million, meaning banking — the larger, slower-growth core — dominates the mix while capital markets provides the higher-margin growth kicker. The key question for the investment case is how much of the 29% headline growth is inorganic; consensus revenue of roughly $15.15 billion for the forward year implies only modest underlying expansion once the acquisition anniversary laps, so the durability of organic growth is the single most important variable to monitor.

Profitability is thin at the bottom line but healthy at the operating level. Q2 2026 net income was $231 million on a 6.84% net margin, with gross margin of 34.76% ($1.174 billion gross profit) and operating margin of 15.01% ($507 million operating income) — the gap between operating and net margin is driven by $200 million of quarterly interest expense and a $212 million negative in other income/expenses. The Q1 2026 quarter is an outlier that must be excluded from trend analysis: net income of $2.366 billion and EPS of $4.59 reflect a $1.946 billion non-operating gain (likely the Worldpay/Global Payments transaction), which is why trailing EPS of $0.011 and a trailing PE of 89.8x look nonsensical. Excluding that distortion, the underlying earnings power is visible in the forward PE of 5.80x against consensus EPS of $7.90, and the 36.86% gross margin is consistent with scaled fintech processing economics, though the 3.58% net margin sits at the low end for the industry and reflects the interest burden from acquisition debt.

Balance-sheet leverage and cash generation are the crux of the risk case. Debt-to-equity stands at 0.959 (total debt to capitalization of 56.9%), and the Q1 2026 cash flow statement shows $7.953 billion of debt repayment alongside $7.859 billion of acquisitions — evidence of a major refinancing tied to the deal. Free cash flow TTM is a solid $2.705 billion, and Q2 2026 FCF was $238 million on $494 million of operating cash flow after $256 million of capex, but the current ratio of 0.589 is well below 1.0, signaling tight near-term liquidity. ROE of 2.75% and ROA of 4.28% are depressed by the interest drag and goodwill-heavy balance sheet, and with dividends of $228 million plus buybacks consuming cash, the company depends on sustained FCF to deleverage — the 2.47% dividend yield is covered but the 221.7% payout ratio on GAAP earnings highlights how distorted reported profitability currently is.

valuation_overview

Quarterly Revenue

$3.4B

2026-06

Revenue YoY Growth

+29.1%

YoY Comparison

Gross Margin

34.8%

Latest Quarter

Free Cash Flow

$2.7B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Banking Solutions
Capital Market Solutions

Open an Account, get $2 TSLA now!

Valuation Analysis: Is FIS Overvalued?

Because trailing net income is positive but distorted to near-zero by the Q1 2026 one-off gain and heavy interest expense, trailing PE of 89.8x is not a meaningful anchor; the appropriate primary metric is the forward PE of 5.80x, which reflects consensus EPS of $7.90 and is the cleanest read on normalized earnings power. The enormous gap between the 89.8x trailing and 5.80x forward multiple implies the market expects earnings to normalize dramatically as acquisition-related charges and interest costs settle — a gap this wide is a red flag that reported earnings quality is poor and that investors are underwriting a substantial earnings recovery. As a cross-check, EV/EBITDA of 16.24x and price-to-sales of 3.22x suggest the stock is not statistically cheap on an enterprise basis despite the low forward PE.

Peer comparison is constrained because the provided valuation dataset contains no explicit industry-average multiples, so a precise premium/discount spread cannot be computed from the data. That said, a 5.80x forward PE and 3.22x P/S are optically deep-value versus the broader technology-services complex, where mid-teens to low-twenties forward multiples are typical, implying a potential discount of 50% or more — but that discount is plausibly justified by the 3.58% net margin, 0.96 debt-to-equity, and sub-1.0 current ratio, all of which are inferior to higher-quality processors. The 2.47x price-to-book and 11.60x price-to-cash-flow are less extreme, suggesting the market is pricing balance-sheet and earnings-quality risk rather than a pure growth discount.

Historical context reinforces the de-rating story. FIS's own PE history shows a swing from 128.1x in Q1 2025 to 2.56x in Q1 2026 (the one-off gain quarter) and 16.78x in Q4 2025, while P/S has compressed from 16.34x in Q2 2025 to 5.94x in Q2 2026 and 3.22x currently — the stock is trading near the bottom of its multi-year valuation band on sales. The PEG ratio of -1.88 is negative and therefore not interpretable, and the 2.47x P/B is near the low end of its 1.0x-3.0x historical range. Trading at the low end of its own band can signal either a genuine value opportunity or fundamental deterioration; given the leverage and margin profile, the market appears to be pricing the latter, and re-rating requires evidence of organic growth and deleveraging.

analyst_targets

PE

89.8x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 3x~57x

vs. Industry Avg

26.1x

Industry PE ~26.1x*

EV/EBITDA

16.2x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on a balance sheet stretched by the issuer-processing acquisition. Debt-to-equity of 0.959 (56.9% debt-to-capitalization) and a current ratio of 0.589 leave thin near-term liquidity, while $200 million of quarterly interest expense consumes roughly two-thirds of the $295 million Q2 2026 pre-tax income. The 3.58% net margin and 2.75% ROE sit at the low end for scaled processors, and with a 221.7% GAAP payout ratio the dividend depends entirely on the $2.705 billion TTM free cash flow holding up. Any FCF shortfall would force a choice between deleveraging, buybacks, and the dividend — a trilemma that caps upside until debt is reduced.

Market and competitive risks are dominated by valuation compression and execution skepticism. The 5.80x forward PE is optically cheap, but EV/EBITDA of 16.24x and P/S of 3.22x show the stock is not statistically cheap on an enterprise basis, so the 'deep value' label depends on earnings normalization that has not yet materialized. Beta of 0.828 means FIS is ~17% less volatile than the market, yet the -52.69% max drawdown proves low beta offered no protection against idiosyncratic de-rating. Competition from Fiserv, Jack Henry, and Broadridge in core banking, plus the risk that the portfolio reset destroys rather than creates value, keeps the analyst range at a bimodal $37-$77 with recent downgrades (Wells Fargo, UBS) outnumbering upgrades.

Worst-case scenario: integration of the issuer-processing business stalls, organic growth decelerates toward low single digits as the acquisition laps, interest costs stay elevated, and a weak quarter triggers further downgrades and momentum selling. In that chain, the stock retests the $32.10 52-week low — about -16.7% from $38.55 — and a break below it (the October shelf at $32.44-$33.10 already failed once) opens a fresh leg lower toward the $37 analyst low or below. Realistically an investor could lose 17% to the 52-week low and 25-30% in a genuine breakdown scenario, consistent with the -52.69% historical max drawdown if the value thesis is fully repudiated.

FAQ

Ranked by severity: first, balance-sheet and liquidity risk — debt-to-equity of 0.959, a current ratio of 0.589, and $200 million of quarterly interest expense consuming roughly two-thirds of Q2 2026's $295 million pre-tax income leave little room for error, and any FCF shortfall against the $2.705 billion TTM figure would force a choice between deleveraging, buybacks, and the 2.47% dividend. Second, earnings-quality and organic-growth risk — the 29.09% revenue growth is largely acquisition arithmetic, gross margin has compressed to 34.76% from 42.45% in Q3 2025, and consensus forward revenue of $15.15 billion implies only modest underlying expansion, so the 5.80x forward PE could prove a value trap. Third, sentiment and momentum risk — the stock is down 38.21% over one year with -49.01% relative strength versus the S&P 500, and Wells Fargo and UBS downgraded in August while the $37-$77 target range signals low conviction. Fourth, competitive and macro risk — pressure from Fiserv, Jack Henry, and Broadridge in core banking, with beta of 0.828 offering limited protection given the -52.69% max drawdown proved idiosyncratic risk dominates.

The 12-month distribution is bimodal with a modest tilt toward the middle. The base case (50% probability) targets $42-$50, centered on the $47.04 analyst average, assuming forward EPS of $7.90 is broadly achieved, organic growth lands in the low-to-mid single digits, and interest expense stays near $200 million per quarter. The bull case (25%) targets $55-$77, requiring visible integration synergies, mid-single-digit organic growth, debt-to-equity below 0.8, and gross margin stabilizing above 36%, with the $77 analyst high implying roughly 100% upside. The bear case (25%) targets $30-$37, driven by decelerating organic growth, gross margin below 33%, a quarterly FCF shortfall, and a break of the $32.10 52-week low. The base case is most likely because the bear case is already largely priced at spot while the bull case needs execution proof that has not yet appeared; the key assumption is that earnings normalize without further multiple compression.

On normalized earnings the stock screens deeply undervalued: the forward PE of 5.80x is far below the mid-teens-to-low-twenties multiples typical of scaled technology-services processors, and P/S of 3.22x sits near the bottom of its own multi-year band after compressing from 16.34x in Q2 2025. The trailing PE of 89.8x is not a meaningful anchor because Q1 2026 EPS of $4.59 was inflated by a $1.946 billion non-operating gain, leaving trailing EPS at just $0.011. On an enterprise basis the discount narrows considerably — EV/EBITDA of 16.24x and EV/sales of 3.31x are not statistically cheap, and P/B of 2.47x and P/CF of 11.60x suggest the market is pricing balance-sheet and earnings-quality risk rather than a pure growth discount. The market is effectively saying it expects earnings normalization to be partial and leverage to persist; a re-rating requires evidence of mid-single-digit organic growth and debt-to-equity falling below 0.8. Verdict: undervalued versus its own history, but only fairly valued on an enterprise basis.

The risk/reward is asymmetric but conditional. At $38.55 the stock trades at 5.80x forward EPS of $7.90 against a 25-analyst average target of $47.04, implying roughly +22% upside, while the $37 low target sits essentially at the current price — meaning the bear case is already largely reflected in the quote. The downside is real, however: a retest of the $32.10 52-week low is about -16.7%, and a genuine breakdown consistent with the -52.69% historical max drawdown would be far worse, driven by 0.959 debt-to-equity, a 0.589 current ratio, and $200 million of quarterly interest expense against a 3.58% net margin. The 29.09% revenue growth is real but heavily acquisition-driven, and gross margin has already fallen to 34.76% from 42.45% in Q3 2025. It is a reasonable buy only for value-oriented investors with a multi-year horizon who size positions for binary integration risk and can tolerate volatility; it is not a good buy for those needing near-term earnings visibility or dependable income.

FIS is better suited to a long-term holding period of at least 18-24 months than to short-term trading, because the thesis depends on integration execution and deleveraging that will only be visible across several quarterly reports. The stock is in a pronounced primary downtrend — down 41.25% YTD and 38.21% over one year — with a -52.69% max drawdown, and the recent 17.17% one-month rally against a -1.81% SPY decline looks more like short-covering off a deep low than a confirmed reversal, given the 2.96 short ratio. Beta of 0.828 means it is roughly 17% less volatile than the market, which supports somewhat larger position sizing, but low beta clearly did not protect holders from severe idiosyncratic de-rating. The 2.47% dividend yield is not a reason to own it, with a 221.7% GAAP payout ratio and FCF committed to debt paydown. Short-term traders should wait for a confirmed hold above the $36-$37 area or a breakout above the $42-$47 resistance zone before engaging.